EUVIMEDDescoperă EUVIMED
FallberichtOpen access · CC BY 4.0

Reactivation of Latent Tuberculosis Following COVID-19 and Epstein-Barr Virus Coinfection: A Case Report

Iryna Halabitska iD, Pavlo Petakh iD, Valentyn Oksenych iD, Oleksandr Kamyshnyi iD

Pathogens · 2025

DOI: 10.3390/pathogens14050488 ↗

At a glance

Fallbericht in Pathogens, 2025. Written by Iryna Halabitska and 3 co-authors. Institution: Department of Therapy and Family Medicine, I. Horbachevsky Ternopil National Medical University, Voli Square, 1, 46001 Ternopil, Ukraine. Major MEDLINE topics: COVID-19, Epstein-Barr Virus Infections, Coinfection, Latent Tuberculosis. Cited 2 times so far (Crossref); 102 references. The full text is freely available (open access, CC BY 4.0).

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Background

This case is unique in demonstrating the reactivation of latent tuberculosis (TB) following co-infection with SARS-CoV-2 and Epstein–Barr virus (EBV) in an otherwise healthy young adult. It highlights a rare clinical scenario in which viral immune dysregulation likely facilitated TB progression. To date, few reports have explored the complex interplay between COVID-19, EBV reactivation, and TB in a single patient, particularly with isolated extrapulmonary involvement. Case Presentation: A 24-year-old woman presented with persistent low-grade fever, fatigue, night sweats, unintentional weight loss, and progressive cervical and supraclavicular lymphadenopathy. These symptoms emerged shortly after a moderate COVID-19 infection. Laboratory studies revealed elevated inflammatory markers and pronounced lymphopenia. EBV reactivation was confirmed via serology and PCR. Despite antiviral therapy, symptoms persisted, and imaging revealed necrotic lymphadenopathy. Tuberculous lymphadenitis was diagnosed through fine-needle aspiration cytology and PCR detection of Mycobacterium tuberculosis. The patient was treated with a standard anti-tuberculosis regimen, resulting in clinical, radiological, and immunological improvement.

Conclusions

This case underscores the importance of considering latent TB reactivation in patients with persistent lymphadenopathy and recent viral infections, particularly in regions with high TB prevalence. It also emphasizes the need for thorough immunological and microbiological assessment in complex post-viral syndromes. The main clinical takeaway is that COVID-19 and EBV co-infection may create a permissive environment for TB reactivation through immune system compromise.

Subjects

MeSH terms (MEDLINE)

COVID-19Epstein-Barr Virus InfectionsCoinfectionLatent TuberculosisHumansFemaleYoung AdultHerpesvirus 4, HumanSARS-CoV-2Virus ActivationAntitubercular Agents

Author keywords

COVID-19Epstein–Barr virusMycobacterium tuberculosislymphadenopathylymphopeniascrofuloderma

Substances

Antitubercular Agents

Authors and institutions

  • Department of Therapy and Family Medicine, I. Horbachevsky Ternopil National Medical University, Voli Square, 1, 46001 Ternopil, Ukraine.
  • Department of Biochemistry and Pharmacology, Uzhhorod National University, 88000 Uzhhorod, Ukraine.
  • Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, 5020 Bergen, Norway.
  • Department of Microbiology, Virology, and Immunology, I. Horbachevsky Ternopil National Medical University, 46001 Ternopil, Ukraine.

ORCID profiles: Iryna Halabitska, Pavlo Petakh, Valentyn Oksenych, Oleksandr Kamyshnyi

Cite

APA

Halabitska, I., Petakh, P., Oksenych, V., & Kamyshnyi, O. (2025). Reactivation of Latent Tuberculosis Following COVID-19 and Epstein-Barr Virus Coinfection: A Case Report. Pathogens. https://doi.org/10.3390/pathogens14050488

Vancouver

Halabitska I, Petakh P, Oksenych V, Kamyshnyi O. Reactivation of Latent Tuberculosis Following COVID-19 and Epstein-Barr Virus Coinfection: A Case Report. Pathogens. 2025. doi:10.3390/pathogens14050488

BibTeX
@article{Halabitska2025,
  author = {Halabitska, Iryna and Petakh, Pavlo and Oksenych, Valentyn and Kamyshnyi, Oleksandr},
  title = {Reactivation of Latent Tuberculosis Following COVID-19 and Epstein-Barr Virus Coinfection: A Case Report},
  journal = {Pathogens},
  year = {2025},
  doi = {10.3390/pathogens14050488}
}
Start for free →